Skip to main content

CJC-1295 Protocol

Meaning

The CJC-1295 Protocol refers to the prescribed regimen for administering the synthetic peptide CJC-1295, a long-acting Growth Hormone-Releasing Hormone (GHRH) analog. This specific protocol is designed to achieve a sustained, pulsatile release of endogenous growth hormone from the pituitary gland, avoiding the pharmacological peaks associated with exogenous growth hormone administration. The primary clinical objective is to optimize the physiological benefits of elevated growth hormone and Insulin-like Growth Factor 1 (IGF-1) levels.